[Clinical and laboratory experience in the treatment of epilepsy with barbexaclone. Considerations on 29 cases]. / Experiência clínica e laboratorial no tratamento da epilepsia com barbexaclone. Consideraçoes sobre 29 casos.

Twenty nine patients were treated with barbexaclone for 6-41 months. Eighteen of these patients suffered from grand-mal epilepsy and complete control of the crises was achieved in 16 of them. No alterations were noted in the hemogram, liver or renal function tests. Side effects were minimal and didn't necessitate discontinuing the drug. 25% of the patients also showed a psychological improvement on the medication.